Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

November 01, 2003; Volume 31,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Arison, Byron H.

    1. You have access
      METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
  2. Assang, Carol

    1. You have access
      METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

B

  1. Baillie, Thomas A.

    1. You have access
      METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
  2. Benet, Leslie Z.

    1. You have access
      DISPOSITION OF TACROLIMUS IN ISOLATED PERFUSED RAT LIVER: INFLUENCE OF TROLEANDOMYCIN, CYCLOSPORINE, AND GG918
      Chi-Yuan Wu and Leslie Z. Benet
      Drug Metabolism and Disposition November 2003, 31 (11) 1292-1295; DOI: https://doi.org/10.1124/dmd.31.11.1292
  3. Berry, Loren M.

    1. You have access
      PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
      Chyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. Liu
      Drug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448
  4. Bible, Roy H.

    1. You have access
      PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
      Chyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. Liu
      Drug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448
  5. Braun, Matthew P.

    1. You have access
      BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
  6. Byrnes-Blake, Kelly A.

    1. You have access
      USE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATS
      Elizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael Owens
      Drug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320

C

  1. Cassidy, K. C.

    1. You have access
      PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
  2. Chappell, Alfred

    1. You have access
      PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
  3. Chatterjee, Parnali

    1. You have access
      HUMAN CYTOCHROME P450 INHIBITION AND METABOLIC-INTERMEDIATE COMPLEX FORMATION BY GOLDENSEAL EXTRACT AND ITS METHYLENEDIOXYPHENYL COMPONENTS
      Parnali Chatterjee and Michael R. Franklin
      Drug Metabolism and Disposition November 2003, 31 (11) 1391-1397; DOI: https://doi.org/10.1124/dmd.31.11.1391
  4. Cherrington, Nathan J.

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
    2. You have access
      CONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATS
      Supratim Choudhuri, Nathan J. Cherrington, Ning Li and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1337-1345; DOI: https://doi.org/10.1124/dmd.31.11.1337
  5. Choudhuri, Supratim

    1. You have access
      CONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATS
      Supratim Choudhuri, Nathan J. Cherrington, Ning Li and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1337-1345; DOI: https://doi.org/10.1124/dmd.31.11.1337
  6. Cook, Chyung S.

    1. You have access
      PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
      Chyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. Liu
      Drug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448
  7. Cramer, J. W.

    1. You have access
      PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
  8. Cui, Donghui

    1. You have access
      METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
  9. Cummins, Len

    1. You have access
      PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419

D

  1. Dalvie, Deepak K.

    1. You have access
      MECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFEN
      John P. O'Donnell, Deepak K. Dalvie, Amit S. Kalgutkar and R. Scott Obach
      Drug Metabolism and Disposition November 2003, 31 (11) 1369-1377; DOI: https://doi.org/10.1124/dmd.31.11.1369
  2. Duanmu, Zhengbo

    1. You have access
      TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION
      Hai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378
  3. Dunbar, Debbie

    1. You have access
      CHARACTERIZATION OF MOUSE SMALL INTESTINAL CYTOCHROME P450 EXPRESSION
      Qing-Yu Zhang, Debbie Dunbar and Laurence S. Kaminsky
      Drug Metabolism and Disposition November 2003, 31 (11) 1346-1351; DOI: https://doi.org/10.1124/dmd.31.11.1346

F

  1. Fang, Hai-Lin

    1. You have access
      TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION
      Hai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378
  2. Farid, N. A.

    1. You have access
      PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
  3. Franklin, Michael R.

    1. You have access
      HUMAN CYTOCHROME P450 INHIBITION AND METABOLIC-INTERMEDIATE COMPLEX FORMATION BY GOLDENSEAL EXTRACT AND ITS METHYLENEDIOXYPHENYL COMPONENTS
      Parnali Chatterjee and Michael R. Franklin
      Drug Metabolism and Disposition November 2003, 31 (11) 1391-1397; DOI: https://doi.org/10.1124/dmd.31.11.1391
  4. Fukumoto, Hiroyuki

    1. You have access
      METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
  5. Fukushima, Yoko

    1. You have access
      METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
  6. Furuta, Takashi

    1. You have access
      EVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS
      Takashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji Kasuya
      Drug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283

G

  1. Gadberry, M. G.

    1. You have access
      PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
  2. Gasiewicz, Thomas A.

    1. You have access
      THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR
      Aby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. Reiners
      Drug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279
  3. Geary, Richard S.

    1. You have access
      PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
  4. Geer, Leslie A.

    1. You have access
      METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
  5. Geng, Wanping

    1. You have access
      A METHOD FOR IDENTIFICATION OF INHIBITION MECHANISM AND ESTIMATION OF KI IN IN VITRO ENZYME INHIBITION STUDY
      Wanping Geng
      Drug Metabolism and Disposition November 2003, 31 (11) 1456-1457; DOI: https://doi.org/10.1124/dmd.31.11.1456
  6. Gentry, W. Brooks

    1. You have access
      USE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATS
      Elizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael Owens
      Drug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320
  7. Gibson, Christopher R.

    1. You have access
      BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
  8. Greenblatt, David J.

    1. You have access
      THE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMES
      Jill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306
  9. Grillo, Mark P.

    1. You have access
      STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE
      Mark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. Ware
      Drug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
    2. You have access
      IDENTIFICATION OF ZOMEPIRAC-S-ACYL-GLUTATHIONE IN VITRO IN INCUBATIONS WITH RAT HEPATOCYTES AND IN VIVO IN RAT BILE
      Mark P. Grillo and Fengmei Hua
      Drug Metabolism and Disposition November 2003, 31 (11) 1429-1436; DOI: https://doi.org/10.1124/dmd.31.11.1429

H

  1. Hajdu, Elisabeth

    1. You have access
      PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
      Chyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. Liu
      Drug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448
  2. Halpin, Rita A.

    1. You have access
      METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
  3. Hardee, Greg E.

    1. You have access
      PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
  4. Harmatz, Jerold S.

    1. You have access
      THE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMES
      Jill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306
  5. Hayakawa, Hiroyoshi

    1. You have access
      METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
  6. Hazai, Eszter

    1. You have access
      GYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCER
      Viola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin Monostory
      Drug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310
  7. Henry, Scott P.

    1. You have access
      PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
  8. Ho, Jonathan Z.

    1. You have access
      BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
  9. Hribar, Jeremy D.

    1. You have access
      PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
      Chyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. Liu
      Drug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448
  10. Hua, Fengmei

    1. You have access
      STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE
      Mark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. Ware
      Drug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
    2. You have access
      IDENTIFICATION OF ZOMEPIRAC-S-ACYL-GLUTATHIONE IN VITRO IN INCUBATIONS WITH RAT HEPATOCYTES AND IN VIVO IN RAT BILE
      Mark P. Grillo and Fengmei Hua
      Drug Metabolism and Disposition November 2003, 31 (11) 1429-1436; DOI: https://doi.org/10.1124/dmd.31.11.1429
  11. Huang, Wendong

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315

I

  1. Ingelman-Sundberg, Magnus

    1. You have access
      GYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCER
      Viola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin Monostory
      Drug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310

J

  1. Jackson, D. A.

    1. You have access
      PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
  2. Jekerle, Veronika

    1. You have access
      INDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORS
      Shirley Teng, Veronika Jekerle and Micheline Piquette-Miller
      Drug Metabolism and Disposition November 2003, 31 (11) 1296-1299; DOI: https://doi.org/10.1124/dmd.31.11.1296
  3. Joiakim, Aby

    1. You have access
      THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR
      Aby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. Reiners
      Drug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279

K

  1. Kadota, Takumi

    1. You have access
      METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
  2. Kalgutkar, Amit S.

    1. You have access
      MECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFEN
      John P. O'Donnell, Deepak K. Dalvie, Amit S. Kalgutkar and R. Scott Obach
      Drug Metabolism and Disposition November 2003, 31 (11) 1369-1377; DOI: https://doi.org/10.1124/dmd.31.11.1369
  3. Kaminsky, Laurence S.

    1. You have access
      CHARACTERIZATION OF MOUSE SMALL INTESTINAL CYTOCHROME P450 EXPRESSION
      Qing-Yu Zhang, Debbie Dunbar and Laurence S. Kaminsky
      Drug Metabolism and Disposition November 2003, 31 (11) 1346-1351; DOI: https://doi.org/10.1124/dmd.31.11.1346
  4. Kasuya, Yasuji

    1. You have access
      EVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS
      Takashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji Kasuya
      Drug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283
  5. Kato, Hiroshi

    1. You have access
      METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
  6. Klaassen, Curtis D.

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
    2. You have access
      CONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATS
      Supratim Choudhuri, Nathan J. Cherrington, Ning Li and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1337-1345; DOI: https://doi.org/10.1124/dmd.31.11.1337
  7. Knutson, Charles G.

    1. You have access
      STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE
      Mark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. Ware
      Drug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
  8. Kocarek, Thomas A.

    1. You have access
      TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION
      Hai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378
  9. Kuehl, Gwendolyn E.

    1. You have access
      N-GLUCURONIDATION OF NICOTINE AND COTININE BY HUMAN LIVER MICROSOMES AND HETEROLOGOUSLY EXPRESSED UDP-GLUCURONOSYLTRANSFERASES
      Gwendolyn E. Kuehl and Sharon E. Murphy
      Drug Metabolism and Disposition November 2003, 31 (11) 1361-1368; DOI: https://doi.org/10.1124/dmd.31.11.1361
  10. Kuroiwa, Hiroyuki

    1. You have access
      METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409

L

  1. Laurenzana, Elizabeth M.

    1. You have access
      USE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATS
      Elizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael Owens
      Drug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320
  2. Levin, Arthur A.

    1. You have access
      PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
  3. Li, Ning

    1. You have access
      CONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATS
      Supratim Choudhuri, Nathan J. Cherrington, Ning Li and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1337-1345; DOI: https://doi.org/10.1124/dmd.31.11.1337
  4. Lin, Charles C.

    1. You have access
      BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
  5. Liu, Norman W.

    1. You have access
      PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS
      Chyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. Liu
      Drug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448
  6. Lu, Ping

    1. You have access
      MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
      Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David Rodrigues
      Drug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
    2. You have access
      METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

M

  1. Ma, Bennett

    1. You have access
      SOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITRO
      Bennett Ma, Magang Shou and Michael L. Schrag
      Drug Metabolism and Disposition November 2003, 31 (11) 1300-1305; DOI: https://doi.org/10.1124/dmd.31.11.1300
  2. Maher, Jonathan M.

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
  3. Mathieu, Patricia A.

    1. You have access
      THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR
      Aby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. Reiners
      Drug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279
  4. Matson, John

    1. You have access
      PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
  5. Mattiuz, E. L.

    1. You have access
      PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
  6. Milesi-Hallé, Alessandra

    1. You have access
      USE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATS
      Elizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael Owens
      Drug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320
  7. Monostory, Katalin

    1. You have access
      GYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCER
      Viola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin Monostory
      Drug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310
  8. Moore, David D.

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
  9. Mori, Chieko

    1. You have access
      EVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS
      Takashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji Kasuya
      Drug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283
  10. Murphy, Sharon E.

    1. You have access
      N-GLUCURONIDATION OF NICOTINE AND COTININE BY HUMAN LIVER MICROSOMES AND HETEROLOGOUSLY EXPRESSED UDP-GLUCURONOSYLTRANSFERASES
      Gwendolyn E. Kuehl and Sharon E. Murphy
      Drug Metabolism and Disposition November 2003, 31 (11) 1361-1368; DOI: https://doi.org/10.1124/dmd.31.11.1361

N

  1. Nishigaki, Junko

    1. You have access
      METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409

O

  1. O'Bannon, D. D.

    1. You have access
      PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
  2. O'Donnell, John P.

    1. You have access
      MECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFEN
      John P. O'Donnell, Deepak K. Dalvie, Amit S. Kalgutkar and R. Scott Obach
      Drug Metabolism and Disposition November 2003, 31 (11) 1369-1377; DOI: https://doi.org/10.1124/dmd.31.11.1369
  3. Obach, R. Scott

    1. You have access
      MECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFEN
      John P. O'Donnell, Deepak K. Dalvie, Amit S. Kalgutkar and R. Scott Obach
      Drug Metabolism and Disposition November 2003, 31 (11) 1369-1377; DOI: https://doi.org/10.1124/dmd.31.11.1369
  4. Owens, S. Michael

    1. You have access
      USE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATS
      Elizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael Owens
      Drug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320

P

  1. Palermo, Christine

    1. You have access
      THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR
      Aby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. Reiners
      Drug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279
  2. Perkins, E. J.

    1. You have access
      PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
  3. Piquette-Miller, Micheline

    1. You have access
      INDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORS
      Shirley Teng, Veronika Jekerle and Micheline Piquette-Miller
      Drug Metabolism and Disposition November 2003, 31 (11) 1296-1299; DOI: https://doi.org/10.1124/dmd.31.11.1296
  4. Pitzenberger, Steven M.

    1. You have access
      BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
  5. Porsmyr-Palmertz, Margareta

    1. You have access
      GYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCER
      Viola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin Monostory
      Drug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310

R

  1. Raab, Conrad E.

    1. You have access
      MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
      Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David Rodrigues
      Drug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
  2. Reiners, John J.

    1. You have access
      THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR
      Aby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. Reiners
      Drug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279
  3. Rodrigues, A. David

    1. You have access
      MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
      Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David Rodrigues
      Drug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
  4. Runge-Morris, Melissa

    1. You have access
      TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION
      Hai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378

S

  1. Sanders, Phillip E.

    1. You have access
      STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE
      Mark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. Ware
      Drug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
  2. Sasmor, Henri

    1. You have access
      PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
  3. Schrag, Michael L.

    1. You have access
      SOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITRO
      Bennett Ma, Magang Shou and Michael L. Schrag
      Drug Metabolism and Disposition November 2003, 31 (11) 1300-1305; DOI: https://doi.org/10.1124/dmd.31.11.1300
    2. You have access
      MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
      Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David Rodrigues
      Drug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
  4. Shader, Richard I.

    1. You have access
      THE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMES
      Jill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306
  5. Shenoy, Sarita

    1. You have access
      TRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTION
      Hai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378
  6. Shibasaki, Hiromi

    1. You have access
      EVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS
      Takashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji Kasuya
      Drug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283
  7. Shou, Magang

    1. You have access
      SOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITRO
      Bennett Ma, Magang Shou and Michael L. Schrag
      Drug Metabolism and Disposition November 2003, 31 (11) 1300-1305; DOI: https://doi.org/10.1124/dmd.31.11.1300
    2. You have access
      MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
      Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David Rodrigues
      Drug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
  8. Silva-Elipe, Maria V.

    1. You have access
      BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
  9. Singh, Rominder

    1. You have access
      BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
  10. Slaughter, Donald

    1. You have access
      METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
  11. Slaughter, Donald E.

    1. You have access
      MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR
      Ping Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David Rodrigues
      Drug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
  12. Slitt, Angela L.

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
  13. Subramanian, Raju

    1. You have access
      BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
  14. Suzuki, Atsushi

    1. You have access
      EVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS
      Takashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji Kasuya
      Drug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283

T

  1. Takenaga, Norihiro

    1. You have access
      METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
  2. Tamási, Viola

    1. You have access
      GYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCER
      Viola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin Monostory
      Drug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310
  3. Teng, Shirley

    1. You have access
      INDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORS
      Shirley Teng, Veronika Jekerle and Micheline Piquette-Miller
      Drug Metabolism and Disposition November 2003, 31 (11) 1296-1299; DOI: https://doi.org/10.1124/dmd.31.11.1296
  4. Tsuji, Akira

    1. You have access
      METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409

V

  1. Vereczkey, László

    1. You have access
      GYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCER
      Viola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin Monostory
      Drug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310
  2. Von Moltke, Lisa L.

    1. You have access
      THE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMES
      Jill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306
  3. Vyas, Kamlesh P.

    1. You have access
      METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398

W

  1. Waldon, Daniel J.

    1. You have access
      STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE
      Mark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. Ware
      Drug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
  2. Walle, Thomas

    1. You have access
      THE β-d-GLUCOSIDE AND SODIUM-DEPENDENT GLUCOSE TRANSPORTER 1 (SGLT1)-INHIBITOR PHLORIDZIN IS TRANSPORTED BY BOTH SGLT1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS 1/2
      Thomas Walle and U. Kristina Walle
      Drug Metabolism and Disposition November 2003, 31 (11) 1288-1291; DOI: https://doi.org/10.1124/dmd.31.11.1288
  3. Walle, U. Kristina

    1. You have access
      THE β-d-GLUCOSIDE AND SODIUM-DEPENDENT GLUCOSE TRANSPORTER 1 (SGLT1)-INHIBITOR PHLORIDZIN IS TRANSPORTED BY BOTH SGLT1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS 1/2
      Thomas Walle and U. Kristina Walle
      Drug Metabolism and Disposition November 2003, 31 (11) 1288-1291; DOI: https://doi.org/10.1124/dmd.31.11.1288
  4. Walsh, Deborah J.

    1. You have access
      METABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONS
      Donald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. Baillie
      Drug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
  5. Wan, Yu-Jui Yvonne

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
  6. Ware, Joseph A.

    1. You have access
      STUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILE
      Mark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. Ware
      Drug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
  7. Warrington, Jill S.

    1. You have access
      THE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMES
      Jill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. Greenblatt
      Drug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306
  8. Watanabe, Tanya

    1. You have access
      PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
  9. Weiss, H. J.

    1. You have access
      PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
  10. Wheeler, W. J.

    1. You have access
      PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
  11. Williams, D. Keith

    1. You have access
      USE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATS
      Elizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael Owens
      Drug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320
  12. Wood, P. G.

    1. You have access
      PRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATS
      E. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. Cassidy
      Drug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
  13. Wu, Chi-Yuan

    1. You have access
      DISPOSITION OF TACROLIMUS IN ISOLATED PERFUSED RAT LIVER: INFLUENCE OF TROLEANDOMYCIN, CYCLOSPORINE, AND GG918
      Chi-Yuan Wu and Leslie Z. Benet
      Drug Metabolism and Disposition November 2003, 31 (11) 1292-1295; DOI: https://doi.org/10.1124/dmd.31.11.1292

Y

  1. Yamamoto, Hiroyuki

    1. You have access
      METABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERS
      Hiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira Tsuji
      Drug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
  2. Yergey, James L.

    1. You have access
      BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
  3. Yokokawa, Akitomo

    1. You have access
      EVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANS
      Takashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji Kasuya
      Drug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283
  4. Yu, Rosie Z.

    1. You have access
      PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES
      Richard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. Levin
      Drug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
  5. Yu, Xiao

    1. You have access
      BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR
      Raju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder Singh
      Drug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437

Z

  1. Zhang, Jun

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
  2. Zhang, Qing-Yu

    1. You have access
      CHARACTERIZATION OF MOUSE SMALL INTESTINAL CYTOCHROME P450 EXPRESSION
      Qing-Yu Zhang, Debbie Dunbar and Laurence S. Kaminsky
      Drug Metabolism and Disposition November 2003, 31 (11) 1346-1351; DOI: https://doi.org/10.1124/dmd.31.11.1346
  3. Zhang, Xiao-Xue

    1. You have access
      INDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTOR
      Nathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. Klaassen
      Drug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 31 (11)
Drug Metabolism and Disposition
Vol. 31, Issue 11
1 Nov 2003
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics